European Journal of Internal Medicine
Volume 17, Issue 7 , Pages 465-469 , November 2006

Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal women

  • Janneke G. Langendonk

      Affiliations

    • Department of General Internal Medicine, Leiden University Medical Centre, Postbox 9600, Albinusdreef 2, 2300RC, Leiden, The Netherlands
    • ,
  • Petra Kok

      Affiliations

    • Department of General Internal Medicine, Leiden University Medical Centre, Postbox 9600, Albinusdreef 2, 2300RC, Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 71 526 9000; fax: +31 71 524 8140.
    • ,
  • Marijke Frölich

      Affiliations

    • Department of Clinical Chemistry, Leiden University Medical Centre, Albinusdreef 2, 2300RC, The Netherlands
    • ,
  • Hanno Pijl

      Affiliations

    • Department of General Internal Medicine, Leiden University Medical Centre, Postbox 9600, Albinusdreef 2, 2300RC, Leiden, The Netherlands
    • ,
  • A. Edo Meinders

      Affiliations

    • Department of General Internal Medicine, Leiden University Medical Centre, Postbox 9600, Albinusdreef 2, 2300RC, Leiden, The Netherlands

Received 5 August 2005 ,Revised 2 April 2006 ,Accepted 11 April 2006.

References 

  1. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761–811
  2. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–131
  3. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet. 1998;351:853–856
  4. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401–1405
  5. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984;289:1257–1261
  6. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667–687
  7. Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes. 1991;15:853–859
  8. Dennis KE, Goldberg AP. Differential effects of body fatness and body fat distribution on risk factor for cardiovascular disease in women. Impact of weight loss. Arterioscler Thromb. 1993;13:1487–1494
  9. Fuller NJ, Sawyer MB, Elia M. Comparative evaluation of body composition methods and predictions, and calculation of density and hydration fraction of fat-free mass, in obese women. Int J Obes Relat Metab Disord. 1994;18:503–512
  10. Gray DS, Fujioka K, Colletti PM, Kim H, Devine W, Cuyegkeng T, et al. Magnetic-resonance imaging used for determining fat distribution in obesity and diabetes. Am J Clin Nutr. 1991;54:623–627
  11. Langendonk JG, Pijl H, Toornvliet AC, Burggraaf J, Frolich M, Schoemaker RC, et al. Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab. 1998;83:1706–1712
  12. Grundy SM. Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am J Cardiol. 2002;90:11i–21i
  13. Beck-Nielsen H. General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR). Drugs. 1999;58(Suppl 1):7–10
  14. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med. 2004;21:383–387
  15. van der KK, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ. Waist–hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr. 1993;57:327–333
  16. Lonnqvist F, Thome A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 1995;95:1109–1116
  17. Nicklas BJ, Rogus EM, Colman EG, Goldberg AP. Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women. Am J Physiol. 1996;270:E72–E78
  18. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132–1143
  19. Kanaley JA, Andresen-Reid ML, Oenning L, Kottke BA, Jensen MD. Differential health benefits of weight loss in upper-body and lower-body obese women. Am J Clin Nutr. 1993;57:20–26
  20. Krotkiewski M, Bjorntorp P. Muscle tissue in obesity with different distribution of adipose tissue. Effects of physical training. Int J Obes. 1986;10:331–341
  21. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ. 1994;308:367–372

PII: S0953-6205(06)00187-7

doi: 10.1016/j.ejim.2006.04.011

European Journal of Internal Medicine
Volume 17, Issue 7 , Pages 465-469 , November 2006

Article Tools

* Image Usage & Resolution